Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
Southport inquiry : killer’s father ‘sorry’ for failing to deal with son’s violent behaviour
5/11/2025
The Guardian view on Zohran Mamdani’s victory in New York : the Democrats can build on an uplifting night | Editorial
5/11/2025
The Guardian view on the Francis curriculum review : raising the right questions in a world with few certain answers | Editorial
5/11/2025
Zohran Mamdani announces all-female transition team as he prepares for New York mayoralty
5/11/2025
Marks & Spencer’s cyber-trauma is bad, but clearly manageable
5/11/2025
Jeremy Vine tells court Joey Barton’s ‘paedophile’ claims put him in physical danger
5/11/2025